000 01246 a2200349 4500
005 20250514155414.0
264 0 _c20031202
008 200312s 0 0 eng d
022 _a0006-291X
024 7 _a10.1016/j.bbrc.2003.08.134
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFukino, Keiko
245 0 0 _aGenetic background influences therapeutic effectiveness of VEGF.
_h[electronic resource]
260 _bBiochemical and biophysical research communications
_cOct 2003
300 _a143-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aBase Sequence
650 0 4 _aDNA Primers
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aNeovascularization, Physiologic
_xdrug effects
650 0 4 _aSpecies Specificity
650 0 4 _aTransfection
650 0 4 _aVascular Endothelial Growth Factor A
_xgenetics
700 1 _aSata, Masataka
700 1 _aSeko, Yoshinori
700 1 _aHirata, Yasunobu
700 1 _aNagai, Ryozo
773 0 _tBiochemical and biophysical research communications
_gvol. 310
_gno. 1
_gp. 143-7
856 4 0 _uhttps://doi.org/10.1016/j.bbrc.2003.08.134
_zAvailable from publisher's website
999 _c14272430
_d14272430